Skip to main content
Clinical Trials/NCT05485181
NCT05485181
Completed
Not Applicable

Validating Promoted Spiritual Experience: A Pilot Study

Rutgers, The State University of New Jersey1 site in 1 country16 target enrollmentJanuary 20, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Addiction
Sponsor
Rutgers, The State University of New Jersey
Enrollment
16
Locations
1
Primary Endpoint
NIH-HEALS
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This pilot study of 16 patients will demonstrate a specific psychologically focused intervention to affect a spiritual aspect of psychological health and will measure (1) its effects on general distress, depression, anxiety and well-being; (2) healing and psychological impact beyond that accounted by usual personality factors; (3) its effect in correlation to measures of spirituality; (4) with neuroimaging, possible biological changes associated with this intervention.

A. Objectives

  1. Pilot a psychological intervention that impacts a "spiritual" level.
  2. Measure efficacy improving well-being beyond explanation by usual personality factors.
  3. Identify biological changes with neuroimaging.

B. Hypotheses / Research Question(s) Studies demonstrate a healing effect beyond usual psychological and medical health to include a "spiritual" aspect with added experience of wholeness and well-being. Benefits are beyond just symptom relief but methods to achieve this are not well-defined. This study will provide a specific intervention and measure psychological and neuroimaging effects of the intervention.

Hypotheses of Specific Results (see Study Instruments below)

  1. DASS-21-shows significant decrease in depression, anxiety and overall stress.
  2. PCL-5 - shows decrease 5-10 points (5 points=response, 10 points=clinically meaningful).
  3. NIH-HEALS - shows significant increase overall and in all 3 factors.
  4. WEMWBS - shows increase of greater than 3 points, considered "meaningful change."
  5. Contingencies of Self-Worth Scale-shows significant global increase, positively correlated with increase in Mysticism Scale scores with post-intervention total above standardized mean.
  6. A relevant portion of outcome improvement on DASS-21, NIH-HEALS, and ASPIRES will NOT be accountable by personality factors measured by NEO-FFI-3.
  7. ASPIRES-shows significant increase in transcendence, no change in religious sentiments.
  8. Neuroimaging-shows reduced activity in SPL, TPJ, MPFC, and IPL (see Research Significance).

Detailed Description

Following IRB approval, recruit 16 patients from a male residential addiction treatment program for a 10-session intervention. 8 subjects will be given pre and post intervention psychological assessments and pre and post fMRIs. Another 8 subjects will serve as a control group and will receive the pre and post (without intervention) psychological assessments at the same time as the previous group and will then be the next 8 subjects to receive the intervention after completion of the first cohort. They will have MRIs before their intervention and post-intervention, thus serving as their own control group. The behavioral intervention occurs with a beginning 3 hour group introduction done by Dr. Chatlos followed by 9 weekly 1 ½ hour group sessions. The subjects' intervention will be recorded for further manual development. The Intervention is a CBT- based psychotherapeutic process that occurs in a group setting with two cohorts of 8 subjects each. It will occur in an introductory 3-hour session followed by 9 weekly 1 ½ hour sessions. In this process, self-worth (self-confidence, self-esteem, self-competence) and dignity (reason, compassion, courage) as operationally defined are strengthened through an interpersonal, psychological process including mindful self-awareness training, attitude transformation with self-compassion, forgiveness, and self-acceptance, and opens to a new level of awareness. This awareness opens to spiritual / numinous features of connectedness, vitality, wholeness, meaning, and serenity that are predicted to be associated with greater well-being and relief of anxiety and depression symptoms.

Registry
clinicaltrials.gov
Start Date
January 20, 2023
End Date
October 1, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Sequential
Sex
Male

Investigators

Responsible Party
Principal Investigator
Principal Investigator

John Calvin Chatlos, MD

Medical Director SATS

Rutgers, The State University of New Jersey

Eligibility Criteria

Inclusion Criteria

  • Recently admitted (within 3 months) male patients of a residential addiction treatment program that has a 6 month average duration.
  • Age 21 or older.
  • Volunteer for the study after a brief introduction.

Exclusion Criteria

  • No psychosis, no suicidal ideation or psychiatric hospitalization in past 3 months.
  • Usual MRI Exclusionary Criteria detailed in IRB

Outcomes

Primary Outcomes

NIH-HEALS

Time Frame: 12 weeks

(NIH-Healing Experience of All Life Stressors) (Ameli et al, 2018): 35-item Likert scale strongly disagree 1 to 5 strongly agree. 3 factor structure:connection (range 10-50), reflection (range 14-70 \& trust \& acceptance (range 11-55. Total range: 35-175. Higher score is better. Expected change in all 3 scales.

fMRI Scan

Time Frame: 12 weeks

fMRI Neuroimaging-will show change in activity in MPFC, SPL, TPJ, and IPL

Secondary Outcomes

  • Transcendence(12 weeks)
  • Depression, Anxiety, Stress(12 weeks)
  • Well-Being(12 weeks)
  • Personally Independent Effects(12 weeks)
  • PTSD(12 weeks)

Study Sites (1)

Loading locations...

Similar Trials